EUGENE REYNOLDS: Open Payments
NPI 1518963594 · GASTONIA, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,307 in 67 payments from 17 companies in 2025. Trend: 2023 $574 · 2024 $1,206 · 2025 $1,307
Food & beverage: $1,307
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 18 | $403 |
| Gilead Sciences, Inc. | 8 | $160 |
| ABBVIE INC. | 6 | $126 |
| AstraZeneca Pharmaceuticals LP | 5 | $83 |
| Merck Sharp & Dohme LLC | 4 | $80 |
| GlaxoSmithKline, LLC. | 4 | $78 |
| Lilly USA, LLC | 4 | $69 |
| Novo Nordisk Inc | 3 | $48 |
| Otsuka America Pharmaceutical, Inc. | 2 | $47 |
| SHIELD THERAPEUTICS INC | 2 | $39 |
Products named: CABENUVA, APRETUDE, DOVATO, PIFELTRO, QULIPTA, SHINGRIX, MOUNJARO, Wegovy.
Industry payments across NC — which companies pay providers there.
